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Background: Cruciferous vegetables have been suggested to protect against various cancers, though the issue is
open to discussion. To further understand their role, we analyzed data from a network of case–control studies
conducted in Italy and Switzerland.
Patients and methods: The studies included a total of 1468 cancers of the oral cavity/pharynx, 505 of the
esophagus, 230 of the stomach, 2390 of the colorectum, 185 of the liver, 326 of the pancreas, 852 of the larynx, 3034
of the breast, 367 of the endometrium, 1031 of the ovary, 1294 of the prostate, 767 of the kidney, and 11 492 controls.
All cancers were incident, histologically conﬁrmed; controls were subjects admitted to the same network of hospitals as
cases for a wide spectrum of acute nonneoplastic conditions.
Results: The multivariate odds ratio (OR) for consumption of cruciferous vegetables at least once a week as compared
with no/occasional consumption was signiﬁcantly reduced for cancer of the oral cavity/pharynx (OR = 0.83), esophagus
(OR = 0.72), colorectum (OR = 0.83), breast (OR = 0.83), and kidney (OR = 0.68). The OR was below unity, but not
signiﬁcant, for stomach (OR = 0.90), liver (OR = 0.72), pancreatic (OR = 0.90), laryngeal (OR = 0.84), endometrial (OR =
0.93), ovarian (OR = 0.91), and prostate (OR = 0.87) cancer.
Conclusion: This large series of studies provides additional evidence of a favorable effect of cruciferous vegetables on
several common cancers.
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introduction
The issue of vegetables and cancer risk has long been
considered in the absence, however, of deﬁnite quantiﬁcation
[1, 2].
Cruciferous vegetables have been of speciﬁc interest due to
their content in glucosinolates, whose major breakdown
products [isothiocyanates (ITCs) and indoles] have
anticarcinogenic properties in in vitro and animal studies [3–
5]. Glucosinolates are converted to ITCs and indoles through
myrosinase activity, a β-thioglucosidase enzyme found in
vacuoles and activated following mastication or cutting of plant
tissue [6]. Most of the ITCs are metabolized in vivo through
the mercapturic acid pathway; indole compounds can react
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with ascorbic acid producing ascorbigen and, at the low pH of
the stomach, a series of condensed products that may act as
further bioactive compounds [6].
Relatively few epidemiological studies have evaluated the
speciﬁc role of cruciferous vegetables on cancer risk [4, 7].
Inverse associations have been reported in case–control studies
on cancers of the stomach, colon, lung, and breast [4, 7–12],
although the evidence from cohort studies has been less
convincing [4, 13]. Data are scanty and inconclusive for other
selected neoplasms [1, 4, 7, 14–18].
In order to add further information on this issue, we
considered the association between cruciferous vegetables and
the risk of several common cancers using data from a network
of case–control studies conducted in Italy and Switzerland.
materials and methods
Between 1991 and 2009, we conducted an integrated series of case–control
studies on various neoplasms in different areas of Northern (the greater
Milan area; the provinces of Pordenone, Padua, Udine, Gorizia and Forlì;
the urban area of Genoa), Central (the provinces of Rome and Latina), and
Southern (the urban area of Naples) Italy. We also conducted companion
studies on cancers of the oral cavity and pharynx, esophagus, colorectum,
larynx, and breast in the canton of Vaud, Switzerland. The studies included
a total of 1468 cases of cancer of the oral cavity and pharynx [19–21], 505
of the esophagus [22, 23], 230 of the stomach [24], 2390 of the colorectum
[25, 26], 185 of the liver [27], 326 of the pancreas [28], 852 of the larynx
[29], 3034 of the breast [30, 31], 367 of the endometrium [32], 1031 of the
ovary [33], 1294 of the prostate [34], 767 of the kidney [35], and a total of
11 492 controls (Table 1).
Cases were incident histologically conﬁrmed cancers, identiﬁed in the
major teaching and general hospitals of the study areas. Controls were
subjects admitted to the same network of hospitals as cases for a wide
spectrum of acute nonneoplastic conditions unrelated to known risk factors
for the corresponding cancer site. Overall, 7.2% of controls were admitted
for traumatic conditions, 23.1% for nontraumatic orthopedic conditions,
32.7% for acute surgical conditions, and 37.1% for miscellaneous other
illnesses. The proportion of refusal of subjects approached was <5% in Italy
and ∼15% in Switzerland. The study protocols were revised and approved
by the ethical committees of the hospitals involved according to the
regulations at the time of study conduction, and all participants gave
informed consent.
Trained personnel interviewed cases and controls during their hospital
stay using a structured questionnaire, including information on
sociodemographic characteristics, anthropometric measures, lifestyle habits
(e.g. tobacco smoking, alcohol drinking), dietary habits, personal medical
history, family history of cancer, and, for women, menstrual and
reproductive factors, use of oral contraceptives (OCs), and hormone
replacement therapy (HRT). Subjects’ usual diet 2 years before diagnosis
(or hospital admission, for controls) was investigated using a reproducible
and valid 78-item food frequency questionnaire (FFQ), which included a
speciﬁc question on weekly consumption of cruciferous vegetables
(cabbages, cauliﬂowers, broccoli, brussels sprouts, and turnip greens) [36,
37]. Seasonal consumption of cruciferous vegetables and the corresponding
duration was also considered.
Odds ratios (ORs) for each cancer site according to the consumption of
cruciferous vegetables and the corresponding 95% conﬁdence intervals
(CIs) were estimated by unconditional multiple logistic regression models
[38]. The models included terms for sex, age, study center, year of
interview, education, alcohol drinking, tobacco smoking, body mass index,
and total energy intake. For breast, ovarian, and endometrial cancer,
models further included parity, menopausal status, age at menopause, and
OC and HRT use, and, for breast only, age at ﬁrst birth. ORs were
computed comparing the consumption of at least one portion of
cruciferous vegetables (∼125 g) per week to no or occasional consumption.
Continuous ORs for an increment of one portion per week were also
estimated. All statistical analyses were performed with SAS 9.1 statistical
software (SAS Institute, Cary, NC).
results
Table 2 gives the distribution of cancer cases and controls
according to the consumption of cruciferous vegetables and
the corresponding ORs (also shown in Figure 1A). The ORs
for subjects consuming of at least one portion of cruciferous
vegetables per week as compared with those with no or
occasional consumption were signiﬁcantly below unity for
cancers of the oral cavity and pharynx (OR = 0.83),
esophagus (OR = 0.72), colorectum (OR = 0.83), breast (OR =
0.83), and kidney (OR = 0.68). The point estimates were also
below unity in the absence, however, of signiﬁcant
associations for stomach (OR = 0.90), liver (OR = 0.72),
pancreatic (OR = 0.90), laryngeal (OR = 0.84), endometrial
(OR = 0.93), ovarian (OR = 0.91), and prostatic (OR = 0.87)
cancer. The continuous ORs for one portion per week were
0.82 for oral and pharyngeal, 0.78 for esophageal, 0.84 for
stomach, 0.88 for colorectal, 0.94 for liver, 0.84 for
pancreatic, 0.87 for laryngeal, 0.94 for breast, 0.98 for
endometrial, 0.87 for ovarian, 0.87 for prostate, and 0.78 for
kidney cancer, but signiﬁcant only for cancers of the oral
cavity and pharynx, colorectum, and kidney (Figure 1B).
The estimates did not meaningfully change after adjustment
for fruit or meat, while they were slightly reduced after
allowance for noncruciferous vegetables. This is due to the
colinearity between various types of vegetables.
Table 3 gives the ORs in strata of sex, age (<60, ≥60 years),
tobacco smoking (nonsmokers and current smokers), and
alcohol consumption (<3 drinks/day and ≥3 drinks/day) for
Table 1. Distribution of cases with selected cancers and corresponding
















1190/278 58 2553/1208 58
Esophagus 438/67 60 919/340 60
Stomach 143/87 63 286/261 63
Colorectum 1401/989 62 2586/2357 58
Liver 149/36 66 278/126 65
Pancreas 174/152 63 348/304 63
Larynx 770/82 62 1564/406 61
Breast –/3034 55 –/3392 56
Endometrium –/367 60 –/798 61
Ovary –/1031 56 –/2411 57
Prostate 1294/– 66 1451/– 63
Kidney 494/273 62 988/546 62
Italy and Switzerland, 1991–2009.
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cancer sites signiﬁcantly associated with cruciferous vegetables.
No inverse relation with oral and pharyngeal cancer was found
in women and in moderate drinkers, possibly on account of
the limited number of cases in these strata; for colorectal
cancer, no protection was found for subjects below age 60
years and for heavy drinkers; for kidney cancer, the inverse
association was stronger in younger as compared with older
subjects. However, no signiﬁcant heterogeneity in risk
estimates was observed across any of the other strata
considered.
discussion
The present analysis conﬁrms that cruciferous vegetables have
a beneﬁcial role on the risk of various common cancers, in
particular, those of the upper digestive tract, colorectum,
breast, and kidney.
Our results for colorectum are consistent with the
conclusions of a International Agency for Research on Cancer
working group and the results from a few subsequent
publications showing that the intestine is among the cancer
Table 2. Distribution of cases with selected cancers and controls and corresponding OR and 95% CI, according to consumption of cruciferous vegetables
Cancer site Weekly consumption of cruciferous vegetables Continuous ORa for one
portion/week (95% CI)<1 portion ≥1 portion
Oral cavity and pharynx
Cases:controls 1096/2397 372/1364
ORa (95% CI) 1b 0.83 (0.70–0.98) 0.82 (0.72–0.93)
Esophagus
Cases:controls 409/874 96/385
ORa (95% CI) 1b 0.72 (0.52–0.99) 0.78 (0.60–1.01)
Stomach
Cases:controls 172/400 58/147
ORa (95% CI) 1b 0.90 (0.61–1.30) 0.84 (0.62–1.14)
Colorectum
Cases:controls 1784/3595 606/1348
ORa (95% CI) 1b 0.83 (0.74–0.94) 0.88 (0.80–0.97)
Liver
Cases:controls 122/267 63/137
ORa (95% CI) 1b 0.72 (0.47–1.11) 0.94 (0.65–1.37)
Pancreas
Cases:controlsc 257/510 69/141
ORa (95% CI) 1b 0.90 (0.63–1.30) 0.84 (0.61–1.14)
Larynx
Cases:controlsc 634/1352 217/617
ORa (95% CI) 1b 0.84 (0.67–1.05) 0.87 (0.74–1.03)
Breast
Cases:controls 2293/2384 741/1008
ORa,d (95% CI) 1b 0.83 (0.74–0.94) 0.94 (0.86–1.03)
Endometrium
Cases:controls 248/562 119/236
ORa,e (95% CI) 1b 0.93 (0.68–1.27) 0.98 (0.75–1.28)
Ovary
Cases:controls 744/1816 287/595
ORa,e (95% CI) 1b 0.91 (0.76–1.11) 0.87 (0.74–1.03)
Prostate
Cases:controlsc 1048/1159 246/291
ORa (95% CI) 1b 0.87 (0.70–1.09) 0.87 (0.72–1.06)
Kidney
Cases:controls 598/1129 169/405
ORa (95% CI) 1b 0.68 (0.54–0.84) 0.78 (0.65–0.94)
Italy and Switzerland, 1991–2009.
aEstimates from logistic regression model adjusted for sex (when appropriate), age, study center, year of interview, education, body mass index, alcohol
drinking, tobacco smoking, and total energy intake.
bReference category.
cThe sum does not add up to the total because of some missing values.
dFurther adjusted for age at ﬁrst birth, parity, oral contraceptive and hormone replacement therapy use, and age at menopause.
eFurther adjusted for parity, oral contraceptive and hormone replacement therapy use, and age at menopause.
OR, odds ratio; CI, conﬁdence interval.
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sites for which the evidence of a beneﬁcial effect of cruciferous
vegetables is more convincing [4, 7, 11]. Breast cancer has also
been reported to be inversely related to cruciferous vegetables
[7–9, 39]. Inverse relations for cancers of the oral cavity and
esophagus have been reported in a few other (case–control)
studies, although data for these neoplasms are limited [1, 4,
Figure 1. Odds ratios (OR) of selected cancers and corresponding 95% conﬁdence intervals (CI) according to: (A) regular (≥1 portion/week) consumption
of cruciferous vegetables versus no/occasional consumption (<1 portion/week) and (B) for an increment of one portion of cruciferous vegetables per week.
Italy and Switzerland, 1991–2009. ORs are the estimates from logistic regression model adjusted for sex (when appropriate), age, study center, year of
interview, education, body mass index, alcohol drinking, tobacco smoking, and total energy intake. OR for breast cancer was further adjusted for age at ﬁrst
birth, parity, oral contraceptive and hormone replacement therapy use, and age at menopause; those for ovarian and endometrial cancer were further
adjusted for parity, oral contraceptive and hormone replacement therapy use, and age at menopause.
Table 3. ORa of selected cancers and 95% CI, according to regular (≥1 portion/week) consumption of cruciferous vegetables versus no/occasional
consumption (<1 portion/week), in strata of sex, age, tobacco smoking, and alcohol consumption
Covariate Cancer site
Oral cavity and pharynx Esophagus Colorectum Breastb Kidney
Sex
Men 0.70 (0.57–0.85)c 0.68 (0.48–0.98) 0.82 (0.70–0.96) – 0.81 (0.61–1.07)
Women 1.05 (0.76–1.44)c 0.81 (0.38–1.73) 0.85 (0.70–1.04) 0.83 (0.74–0.94) 0.52 (0.36–0.75)
Age (yearrs)
<60 0.75 (0.60–0.95) 0.59 (0.36–0.97) 1.08 (0.90–1.29)d 0.92 (0.79–1.07) 0.52 (0.37–0.73)c
≥60 0.81 (0.63–1.04) 0.78 (0.51–1.20) 0.71 (0.61–0.83)d 0.73 (0.60–0.88) 0.80 (0.60–1.07)c
Tobacco smoking
Non smokers 0.89 (0.71–1.12) 0.69 (0.44–1.06) 0.82 (0.72–0.94) 0.84 (0.73–0.96) 0.67 (0.51–0.87)
Current smokers 0.68 (0.53–0.88) 0.59 (0.37–0.95) 0.84 (0.67–1.07) 0.78 (0.61–1.01) 0.68 (0.45–1.04)
Alcohol consumption
<3 drinks/day 1.20 (0.83–1.74)d 0.94 (0.33–2.66) 0.66 (0.52–0.83)c 0.91 (0.77–1.07) 0.53 (0.35–0.80)
≥3 drinks/day 0.60 (0.50–0.72)d 0.60 (0.43–0.83) 0.92 (0.80–1.06)c 0.76 (0.64–0.91) 0.74 (0.57–0.96)
Italy and Switzerland, 1991–2009.
aEstimates from logistic regression model adjusted for sex (when appropriate), age, study center, year of interview, education, alcohol drinking, tobacco
smoking, body mass index, and total energy intake.
bFurther adjusted for age at ﬁrst birth, parity, age at menopause, oral contraceptives use, and hormone replacement therapy use.
cP value for interaction <0.05.
dP value for interaction <0.005.
OR, odds ratio; CI, conﬁdence interval.
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40]; these cancers, however, have been consistently related to
low vegetables consumption [1]. Data are even scantier for
kidney cancer [4, 41]. The absence of an inverse relation with
gastric cancer in our data is somewhat in contrast with the
results of previous studies suggesting a beneﬁcial effect of
cruciferous vegetables, although the issue remains open to
discussion [4, 7].
The beneﬁcial effect of cruciferous vegetables on various
common cancers may be due to their high content of several
antioxidants and vitamins, including carotenoids, polyphenols,
vitamin C, and folate [3, 4, 42]. Moreover, they contain high
levels of glucosinolates, whose major breakdown products
(indoles and ITCs) have been shown—in in vitro and animal
studies—to have high anticarcinogenic properties, particularly
on cancers of the digestive tract, liver, lung, and breast [4, 43].
In cultured human cancer cells, ITCs can induce apoptosis and
arrest of cell cycle that are critical processes in the prevention
of tumor growth [3]. Moreover, ITCs seem to inhibit histone
deacetylase activity, which removes acetyl groups from
histones, thus enabling transcription of tumor suppressor
proteins that promote differentiation and apoptosis in
precancerous cells [44]. ITCs can also affect xenobiotic-
metabolizing enzymes that are able to modulate the access of
chemical carcinogens to DNA in target tissues [4, 43, 45]. In
particular, ITCs can modulate expression of phase II enzymes,
while indoles act as bifunctional inducers of both phase I and
phase II enzymes. This mechanism of action can explain the
protection against numerous xenobiotics and carcinogens (e.g.
those produced through tobacco smoke or cooked food
mutagens), and it was demonstrated also in human colon
cancer cell lines following the supplementation with ITCs and
indoles where the induction of phase I and phase II enzymes
was able to protect cells against benzo[a]pyrene-induced DNA
damage [43]. Indoles can also decrease estrogen receptor-α
expression [46]. Through this mechanism, estrogen-dependent
signal transduction that results in breast cancer cell
proliferation would be decreased, thus providing a molecular
basis for the chemopreventive activity against breast cancer.
In the present study, the inverse association with cruciferous
vegetables was stronger in smokers than in nonsmokers in the
absence, however, of signiﬁcant heterogeneity. In a recent
intervention study, smokers had a reduction in both
endogenous and ex vivo-induced DNA damage following the
regular intake of 250 g of steamed broccoli for 10 days, and
this effect was particularly evident in subjects with glutathione-
S-transferase (GST) M1-null genotype [44]. GSTs are involved
in the metabolism of ITCs and may modulate the effect of
cruciferous vegetables on cancer risk [7]. However, we could
not determine the impact of GST M1 polymorphism on our
results.
It is difﬁcult to extrapolate the contribution of a speciﬁc
class of vegetables on cancer risk, and in particular, it is not
possible to disentangle the speciﬁc role of cruciferous
vegetables from that of all vegetables because of their high
correlation.
Our FFQ was not speciﬁcally designed to investigate the
consumption of cruciferous vegetables and did not allow us to
investigate single items of the Brassicaceae family. The intake
of cruciferous vegetables is highly variable in different
populations [4]. Asian and Middle Eastern populations have
relatively high intakes (40–80 g/day) as compared with
European ones (5.7–32.7 g/day) with an estimate in the Italian
population of ∼11.5 g/day [46]. Thus, the low consumption of
cruciferous vegetables in our study population—as in other
European countries [47]—did not allow us to study speciﬁc
levels of consumption. Apart from differences in the total
amount of cruciferous vegetables, the levels of speciﬁc
glucosinolate derived ITCs can vary depending on the
vegetable consumed. As ITCs can have different strength of
activity depending on chemical structure, this may in part
explain discrepant results in the literature.
Our studies have the inherent limitations of case–control
studies, including potential recall and selection bias. However,
cases and controls in our studies came from comparable
catchment areas, were interviewed by uniformly trained
interviewers in the hospital setting, and their participation was
high, thus reducing any such bias. Moreover, we took great
care in excluding from the control group of all diagnoses that
might have lead to long-term modiﬁcations of diet and other
risk factors for the neoplasms considered. Among the strengths
of the study, there are the large sample size, the use of a
reproducible and valid FFQ [36, 37], and the ability to adjust
for total energy intake, as well as for other major potential
confounding factors for the cancers investigated.
In conclusion, this large integrated series of studies provides
additional evidence of a favorable effect of cruciferous
vegetables on several common cancer sites. Promoting the
intake of cruciferous vegetables in populations where
consumption is comparably low should be considered [46].
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